Cyclic adenosine monophosphate as an endogenous modulator of the amyloid‐β precursor protein metabolism. Issue 2 (8th January 2013)

• Record Type: Journal Article
• Authors: Canepa, Elisa; Domenicotti, Cinzia; Marengo, Barbara; Passalacqua, Mario; Marinari, Umberto M.; Pronzato, Maria A.; Fedele, Ernesto; Ricciarelli, Roberta
• Is Part Of: IUBMB life. Volume 65:Issue 2(2013:Feb.)
• Page Start: 127
• Page End: 133
• Publication Date: 2013-01-08
• Subjects: Biochemistry -- Periodicals; Molecular biology -- Periodicals; 572.8
• DOI: 10.1002/iub.1109
• Languages: English
• ISSNs: 1521-6543

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Besides playing a pathogenic role in Alzheimer disease, amyloid‐beta peptides are normally produced in low amounts in the brain, and several lines of evidence suggest that they can modulate synaptic plasticity and memory. As cyclic adenosine monophosphate (cAMP) is known to be involved in the same processes and the blockade of its degradation by phosphodiesterase 4 inhibitors has consistently shown beneficial effects on cognition, we investigated the possible correlation between this second messenger and Aβ peptides in neuronal N2a cells overexpressing the amyloid‐β precursor protein (APP). We herein report that the elevation of endogenous cAMP by rolipram increased APP protein expression and both its amyloidogenic and nonamyloidogenic processing. The effects of rolipram were reproduced by both the cAMP membrane‐permeant analog 8Br‐cAMP and the forskolin‐induced activation of adenylyl cyclase but were not affected by the PKA inhibitor H‐89. Our results demonstrate that, in neuronal cells, APP metabolism is physiologically modulated by cAMP and suggest that this might represent an additional mechanism through which the second messenger could influence memory functions. © 2013 IUBMB Life, 65(2)127–133, 2013</p> </abstract>